- Home
- TIGR vs BLTE Comparison
TIGR vs BLTE Comparison
Compare TIGR & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIGR
- BLTE
- Stock Information
- Founded
- TIGR 2014
- BLTE 2018
- Country
- TIGR Singapore
- BLTE United States
- Employees
- TIGR N/A
- BLTE N/A
- Industry
- TIGR Investment Bankers/Brokers/Service
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- TIGR Finance
- BLTE Health Care
- Exchange
- TIGR Nasdaq
- BLTE Nasdaq
- Market Cap
- TIGR 1.9B
- BLTE 2.1B
- IPO Year
- TIGR 2019
- BLTE 2022
- Fundamental
- Price
- TIGR $10.15
- BLTE $77.01
- Analyst Decision
- TIGR Strong Buy
- BLTE Strong Buy
- Analyst Count
- TIGR 3
- BLTE 4
- Target Price
- TIGR $11.19
- BLTE $96.00
- AVG Volume (30 Days)
- TIGR 5.9M
- BLTE 64.5K
- Earning Date
- TIGR 11-11-2025
- BLTE 11-11-2025
- Dividend Yield
- TIGR N/A
- BLTE N/A
- EPS Growth
- TIGR 305.45
- BLTE N/A
- EPS
- TIGR 0.66
- BLTE N/A
- Revenue
- TIGR $421,673,984.00
- BLTE N/A
- Revenue This Year
- TIGR $62.71
- BLTE N/A
- Revenue Next Year
- TIGR $9.93
- BLTE N/A
- P/E Ratio
- TIGR $15.91
- BLTE N/A
- Revenue Growth
- TIGR 68.66
- BLTE N/A
- 52 Week Low
- TIGR $5.36
- BLTE $49.00
- 52 Week High
- TIGR $14.48
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- TIGR 42.99
- BLTE 70.06
- Support Level
- TIGR $10.02
- BLTE $70.80
- Resistance Level
- TIGR $11.02
- BLTE $74.18
- Average True Range (ATR)
- TIGR 0.50
- BLTE 2.30
- MACD
- TIGR -0.05
- BLTE 0.71
- Stochastic Oscillator
- TIGR 20.52
- BLTE 83.82
About TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.